Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

3. června 2014 aktualizováno: Boehringer Ingelheim

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes

The purposes of this study are:

  1. To evaluate the long-term safety of dabigatran etexilate
  2. To assess the effect of a knowledge translation intervention on patient outcomes

Přehled studie

Postavení

Dokončeno

Podmínky

Intervence / Léčba

Typ studie

Intervenční

Zápis (Aktuální)

5897

Fáze

  • Fáze 3

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

  • Austrálie
    • New South Wales
      • Coffs Harbour, New South Wales, Austrálie
        • 1160.71.0508 Boehringer Ingelheim Investigational Site
      • Gosford, New South Wales, Austrálie
        • 1160.71.0510 Boehringer Ingelheim Investigational Site
    • Queensland
      • Milton, Queensland, Austrálie
        • 1160.71.0506 Boehringer Ingelheim Investigational Site
    • South Australia
      • Ashford, South Australia, Austrálie
        • 1160.71.0509 Boehringer Ingelheim Investigational Site
    • Tasmania
      • Launceston, Tasmania, Austrálie
        • 1160.71.0507 Boehringer Ingelheim Investigational Site
    • Victoria
      • Box Hill, Victoria, Austrálie
        • 1160.71.0504 Boehringer Ingelheim Investigational Site
      • Geelong, Victoria, Austrálie
        • 1160.71.0501 Boehringer Ingelheim Investigational Site
  • Belgie
      • Aalst, Belgie
        • 1160.71.0564 Boehringer Ingelheim Investigational Site
      • Brasschaat, Belgie
        • 1160.71.0572 Boehringer Ingelheim Investigational Site
      • Brussel, Belgie
        • 1160.71.0571 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgie
        • 1160.71.0581 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgie
        • 1160.71.0585 Boehringer Ingelheim Investigational Site
      • Edegem, Belgie
        • 1160.71.0563 Boehringer Ingelheim Investigational Site
      • Genk, Belgie
        • 1160.71.0578 Boehringer Ingelheim Investigational Site
      • Genk, Belgie
        • 1160.71.0587 Boehringer Ingelheim Investigational Site
      • Gent, Belgie
        • 1160.71.0574 Boehringer Ingelheim Investigational Site
      • Gilly, Belgie
        • 1160.71.0588 Boehringer Ingelheim Investigational Site
      • Hasselt, Belgie
        • 1160.71.0568 Boehringer Ingelheim Investigational Site
      • Leuven, Belgie
        • 1160.71.0561 Boehringer Ingelheim Investigational Site
      • Liège, Belgie
        • 1160.71.0579 Boehringer Ingelheim Investigational Site
      • Oostende, Belgie
        • 1160.71.0567 Boehringer Ingelheim Investigational Site
      • Roeselare, Belgie
        • 1160.71.0570 Boehringer Ingelheim Investigational Site
      • Tienen, Belgie
        • 1160.71.0566 Boehringer Ingelheim Investigational Site
      • Turnhout, Belgie
        • 1160.71.0562 Boehringer Ingelheim Investigational Site
  • Brazílie
      • Campinas, Brazílie
        • 1160.71.0644 Boehringer Ingelheim Investigational Site
      • Curitiba, Brazílie
        • 1160.71.0650 Boehringer Ingelheim Investigational Site
      • Curitiba, Brazílie
        • 1160.71.0651 Boehringer Ingelheim Investigational Site
      • Goiania, Brazílie
        • 1160.71.0652 Boehringer Ingelheim Investigational Site
      • Sao Jose do Riio Preto, Brazílie
        • 1160.71.0646 Boehringer Ingelheim Investigational Site
      • São José do Rio Preto, Brazílie
        • 1160.71.0647 Boehringer Ingelheim Investigational Site
      • São Paulo, Brazílie
        • 1160.71.0643 Boehringer Ingelheim Investigational Site
  • Bulharsko
      • Pleven, Bulharsko
        • 1160.71.0620 Boehringer Ingelheim Investigational Site
      • Sofia, Bulharsko
        • 1160.71.0611 Boehringer Ingelheim Investigational Site
      • Sofia, Bulharsko
        • 1160.71.0612 Boehringer Ingelheim Investigational Site
      • Sofia, Bulharsko
        • 1160.71.0615 Boehringer Ingelheim Investigational Site
      • Sofia, Bulharsko
        • 1160.71.0617 Boehringer Ingelheim Investigational Site
      • Sofia, Bulharsko
        • 1160.71.0618 Boehringer Ingelheim Investigational Site
      • Sofia, Bulharsko
        • 1160.71.0625 Boehringer Ingelheim Investigational Site
  • Dánsko
      • Aalborg, Dánsko
        • 1160.71.0837 Boehringer Ingelheim Investigational Site
      • Aarhus C, Dánsko
        • 1160.71.0835 Boehringer Ingelheim Investigational Site
      • Frederikssund, Dánsko
        • 1160.71.0838 Boehringer Ingelheim Investigational Site
      • Helsingør, Dánsko
        • 1160.71.0833 Boehringer Ingelheim Investigational Site
      • Herlev, Dánsko
        • 1160.71.0834 Boehringer Ingelheim Investigational Site
      • Horsens, Dánsko
        • 1160.71.0841 Boehringer Ingelheim Investigational Site
      • Hvidovre, Dánsko
        • 1160.71.0832 Boehringer Ingelheim Investigational Site
      • Køge, Dánsko
        • 1160.71.0840 Boehringer Ingelheim Investigational Site
      • Odense, Dánsko
        • 1160.71.0831 Boehringer Ingelheim Investigational Site
      • Roskilde, Dánsko
        • 1160.71.0839 Boehringer Ingelheim Investigational Site
      • Svendborg, Dánsko
        • 1160.71.0836 Boehringer Ingelheim Investigational Site
  • Filipíny
      • Ermita Manila, Filipíny
        • 1160.71.1422 Boehringer Ingelheim Investigational Site
      • Manila, Filipíny
        • 1160.71.1421 Boehringer Ingelheim Investigational Site
      • Pasig City, Filipíny
        • 1160.71.1424 Boehringer Ingelheim Investigational Site
      • Quezon City, Filipíny
        • 1160.71.1423 Boehringer Ingelheim Investigational Site
      • Quezon City, Filipíny
        • 1160.71.1425 Boehringer Ingelheim Investigational Site
  • Finsko
      • Helsinki, Finsko
        • 1160.71.0851 Boehringer Ingelheim Investigational Site
      • Jyväskylä, Finsko
        • 1160.71.0859 Boehringer Ingelheim Investigational Site
      • Oulu, Finsko
        • 1160.71.0854 Boehringer Ingelheim Investigational Site
      • Pori, Finsko
        • 1160.71.0858 Boehringer Ingelheim Investigational Site
      • Tampere, Finsko
        • 1160.71.0852 Boehringer Ingelheim Investigational Site
      • Turku, Finsko
        • 1160.71.0853 Boehringer Ingelheim Investigational Site
  • Francie
      • ABBEVILLE cedex, Francie
        • 1160.71.875A Boehringer Ingelheim Investigational Site
      • Angers, Francie
        • 1160.71.882D Boehringer Ingelheim Investigational Site
      • Angers, Francie
        • 1160.71.882G Boehringer Ingelheim Investigational Site
      • Besle Sur Vilaine, Francie
        • 1160.71.879F Boehringer Ingelheim Investigational Site
      • Cholet, Francie
        • 1160.71.887A Boehringer Ingelheim Investigational Site
      • Château Gontier, Francie
        • 1160.71.882K Boehringer Ingelheim Investigational Site
      • Derval, Francie
        • 1160.71.879C Boehringer Ingelheim Investigational Site
      • Feneu, Francie
        • 1160.71.882H Boehringer Ingelheim Investigational Site
      • GRENOBLE Cédex 9, Francie
        • 1160.71.888A Boehringer Ingelheim Investigational Site
      • La Chapelle sur Erdre, Francie
        • 1160.71.879B Boehringer Ingelheim Investigational Site
      • Langres, Francie
        • 1160.71.874A Boehringer Ingelheim Investigational Site
      • Laval, Francie
        • 1160.71.884A Boehringer Ingelheim Investigational Site
      • Le Mesnil en Valée, Francie
        • 1160.71.880B Boehringer Ingelheim Investigational Site
      • Murs Erigne, Francie
        • 1160.71.880A Boehringer Ingelheim Investigational Site
      • Nantes, Francie
        • 1160.71.879A Boehringer Ingelheim Investigational Site
      • Nantes, Francie
        • 1160.71.879H Boehringer Ingelheim Investigational Site
      • Nantes, Francie
        • 1160.71.879S Boehringer Ingelheim Investigational Site
      • Parcay les Pins, Francie
        • 1160.71.880J Boehringer Ingelheim Investigational Site
      • Paris, Francie
        • 1160.71.871A Boehringer Ingelheim Investigational Site
      • Saint Aubin Des Chateaux, Francie
        • 1160.71.879E Boehringer Ingelheim Investigational Site
      • Segre, Francie
        • 1160.71.880D Boehringer Ingelheim Investigational Site
      • Tierce, Francie
        • 1160.71.882A Boehringer Ingelheim Investigational Site
      • Tierce, Francie
        • 1160.71.882B Boehringer Ingelheim Investigational Site
      • Tierce, Francie
        • 1160.71.882C Boehringer Ingelheim Investigational Site
      • Vieillevigne, Francie
        • 1160.71.879G Boehringer Ingelheim Investigational Site
      • Vihiers, Francie
        • 1160.71.880E Boehringer Ingelheim Investigational Site
  • Holandsko
      • 's Hertogenbosch, Holandsko
        • 1160.71.1337 Boehringer Ingelheim Investigational Site
      • Almelo, Holandsko
        • 1160.71.1344 Boehringer Ingelheim Investigational Site
      • Amsterdam, Holandsko
        • 1160.71.1331 Boehringer Ingelheim Investigational Site
      • Apeldoorn, Holandsko
        • 1160.71.1336 Boehringer Ingelheim Investigational Site
      • Breda, Holandsko
        • 1160.71.1332 Boehringer Ingelheim Investigational Site
      • Den Helder, Holandsko
        • 1160.71.1349 Boehringer Ingelheim Investigational Site
      • Deventer, Holandsko
        • 1160.71.1345 Boehringer Ingelheim Investigational Site
      • Dirksland, Holandsko
        • 1160.71.1360 Boehringer Ingelheim Investigational Site
      • Ede, Holandsko
        • 1160.71.1340 Boehringer Ingelheim Investigational Site
      • Eindhoven, Holandsko
        • 1160.71.1358 Boehringer Ingelheim Investigational Site
      • Enschede, Holandsko
        • 1160.71.1338 Boehringer Ingelheim Investigational Site
      • Goes, Holandsko
        • 1160.71.1343 Boehringer Ingelheim Investigational Site
      • Gorinchem, Holandsko
        • 1160.71.1347 Boehringer Ingelheim Investigational Site
      • Groningen, Holandsko
        • 1160.71.1333 Boehringer Ingelheim Investigational Site
      • Heerlen, Holandsko
        • 1160.71.1361 Boehringer Ingelheim Investigational Site
      • Hengelo, Holandsko
        • 1160.71.1339 Boehringer Ingelheim Investigational Site
      • Hilversum, Holandsko
        • 1160.71.1346 Boehringer Ingelheim Investigational Site
      • Hoorn, Holandsko
        • 1160.71.1356 Boehringer Ingelheim Investigational Site
      • Maastricht, Holandsko
        • 1160.71.1359 Boehringer Ingelheim Investigational Site
      • Meppel, Holandsko
        • 1160.71.1341 Boehringer Ingelheim Investigational Site
      • Rotterdam, Holandsko
        • 1160.71.1354 Boehringer Ingelheim Investigational Site
      • Sneek, Holandsko
        • 1160.71.1351 Boehringer Ingelheim Investigational Site
      • Tiel, Holandsko
        • 1160.71.1353 Boehringer Ingelheim Investigational Site
      • Tilburg, Holandsko
        • 1160.71.1352 Boehringer Ingelheim Investigational Site
      • Veldhoven, Holandsko
        • 1160.71.1350 Boehringer Ingelheim Investigational Site
      • Velp, Holandsko
        • 1160.71.1342 Boehringer Ingelheim Investigational Site
      • Zwijndrecht, Holandsko
        • 1160.71.1348 Boehringer Ingelheim Investigational Site
  • Hongkong
      • Kowloon, Hongkong
        • 1160.71.1003 Boehringer Ingelheim Investigational Site
      • Kowloon, Hongkong
        • 1160.71.1004 Boehringer Ingelheim Investigational Site
  • Indie
      • Ahmedabad, Indie
        • 1160.71.1057 Boehringer Ingelheim Investigational Site
      • Ahmedabad-52, Indie
        • 1160.71.1056 Boehringer Ingelheim Investigational Site
      • Bangalore, Indie
        • 1160.71.1065 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indie
        • 1160.71.1062 Boehringer Ingelheim Investigational Site
      • Jaipur, Rajasthan, Indie
        • 1160.71.1073 Boehringer Ingelheim Investigational Site
      • Kerala, Indie
        • 1160.71.1067 Boehringer Ingelheim Investigational Site
      • Kottayam, Indie
        • 1160.71.1068 Boehringer Ingelheim Investigational Site
      • Lucknow, Uttar Pradesh, Indie
        • 1160.71.1055 Boehringer Ingelheim Investigational Site
      • Ludhiana, Indie
        • 1160.71.1051 Boehringer Ingelheim Investigational Site
      • Mysore, Indie
        • 1160.71.1072 Boehringer Ingelheim Investigational Site
      • Nagpur-12, Indie
        • 1160.71.1059 Boehringer Ingelheim Investigational Site
      • New Delhi, Indie
        • 1160.71.1052 Boehringer Ingelheim Investigational Site
      • Pune, Maharashtra, Indie
        • 1160.71.1070 Boehringer Ingelheim Investigational Site
  • Itálie
      • Arezzo, Itálie
        • 1160.71.1169 Boehringer Ingelheim Investigational Site
      • Ascoli Piceno, Itálie
        • 1160.71.1172 Boehringer Ingelheim Investigational Site
      • Sassari, Itálie
        • 1160.71.1170 Boehringer Ingelheim Investigational Site
  • Izrael
      • Afula, Izrael
        • 1160.71.1110 Boehringer Ingelheim Investigational Site
      • Afula, Izrael
        • 1160.71.1121 Boehringer Ingelheim Investigational Site
      • Ashkelon, Izrael
        • 1160.71.1111 Boehringer Ingelheim Investigational Site
      • Givatayim, Izrael
        • 1160.71.1117 Boehringer Ingelheim Investigational Site
      • Hadera, Izrael
        • 1160.71.1112 Boehringer Ingelheim Investigational Site
      • Haifa, Izrael
        • 1160.71.1091 Boehringer Ingelheim Investigational Site
      • Haifa, Izrael
        • 1160.71.1113 Boehringer Ingelheim Investigational Site
      • Haifa, Izrael
        • 1160.71.1114 Boehringer Ingelheim Investigational Site
      • Haifa, Izrael
        • 1160.71.1116 Boehringer Ingelheim Investigational Site
      • Haifa, Izrael
        • 1160.71.1118 Boehringer Ingelheim Investigational Site
      • Holon, Izrael
        • 1160.71.1105 Boehringer Ingelheim Investigational Site
      • Jerusalem, Izrael
        • 1160.71.1101 Boehringer Ingelheim Investigational Site
      • Jerusalem, Izrael
        • 1160.71.1104 Boehringer Ingelheim Investigational Site
      • Jerusalem, Izrael
        • 1160.71.1106 Boehringer Ingelheim Investigational Site
      • Kfar Saba, Izrael
        • 1160.71.1119 Boehringer Ingelheim Investigational Site
      • Petah Tikva, Izrael
        • 1160.71.1096 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Izrael
        • 1160.71.1093 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Izrael
        • 1160.71.1094 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Izrael
        • 1160.71.1095 Boehringer Ingelheim Investigational Site
      • Rehovot, Izrael
        • 1160.71.1100 Boehringer Ingelheim Investigational Site
      • Safed, Izrael
        • 1160.71.1103 Boehringer Ingelheim Investigational Site
      • Tel Aviv, Izrael
        • 1160.71.1120 Boehringer Ingelheim Investigational Site
      • Tel Aviv, Izrael
        • 1160.71.1122 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Izrael
        • 1160.71.1107 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Izrael
        • 1160.71.1108 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Izrael
        • 1160.71.1109 Boehringer Ingelheim Investigational Site
  • Kanada
      • Quebec, Kanada
        • 1160.71.0700 Boehringer Ingelheim Investigational Site
    • Alberta
      • Calgary, Alberta, Kanada
        • 1160.71.0694 Boehringer Ingelheim Investigational Site
      • Calgary, Alberta, Kanada
        • 1160.71.0696 Boehringer Ingelheim Investigational Site
    • British Columbia
      • Coquitlam, British Columbia, Kanada
        • 1160.71.0680 Boehringer Ingelheim Investigational Site
      • Coquitlam, British Columbia, Kanada
        • 1160.71.0712 Boehringer Ingelheim Investigational Site
      • Kelowna, British Columbia, Kanada
        • 1160.71.0706 Boehringer Ingelheim Investigational Site
      • Nanaimo, British Columbia, Kanada
        • 1160.71.0725 Boehringer Ingelheim Investigational Site
      • New Westminster, British Columbia, Kanada
        • 1160.71.0691 Boehringer Ingelheim Investigational Site
      • Victoria, British Columbia, Kanada
        • 1160.71.0714 Boehringer Ingelheim Investigational Site
    • Manitoba
      • Portage la Prairie, Manitoba, Kanada
        • 1160.71.0701 Boehringer Ingelheim Investigational Site
    • Nova Scotia
      • Halifax, Nova Scotia, Kanada
        • 1160.71.0703 Boehringer Ingelheim Investigational Site
    • Ontario
      • Burlington, Ontario, Kanada
        • 1160.71.0674 Boehringer Ingelheim Investigational Site
      • Cambridge, Ontario, Kanada
        • 1160.71.0702 Boehringer Ingelheim Investigational Site
      • Cambridge, Ontario, Kanada
        • 1160.71.0720 Boehringer Ingelheim Investigational Site
      • Grimsby, Ontario, Kanada
        • 1160.71.0692 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Kanada
        • 1160.71.0697 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Kanada
        • 1160.71.0710 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Kanada
        • 1160.71.0719 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Kanada
        • 1160.71.0721 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Kanada
        • 1160.71.0708 Boehringer Ingelheim Investigational Site
      • Newmarket, Ontario, Kanada
        • 1160.71.0688 Boehringer Ingelheim Investigational Site
      • Oshawa, Ontario, Kanada
        • 1160.71.0672 Boehringer Ingelheim Investigational Site
      • Ottawa, Ontario, Kanada
        • 1160.71.0687 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Kanada
        • 1160.71.0679 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Kanada
        • 1160.71.0723 Boehringer Ingelheim Investigational Site
      • Sudbury, Ontario, Kanada
        • 1160.71.0715 Boehringer Ingelheim Investigational Site
      • Thunder Bay, Ontario, Kanada
        • 1160.71.0690 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Kanada
        • 1160.71.0684 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Kanada
        • 1160.71.0718 Boehringer Ingelheim Investigational Site
      • Windsor, Ontario, Kanada
        • 1160.71.0686 Boehringer Ingelheim Investigational Site
    • Quebec
      • Montreal, Quebec, Kanada
        • 1160.71.0683 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Kanada
        • 1160.71.0705 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Kanada
        • 1160.71.0709 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Kanada
        • 1160.71.0716 Boehringer Ingelheim Investigational Site
      • Quebec City, Quebec, Kanada
        • 1160.71.0717 Boehringer Ingelheim Investigational Site
      • St. Charles-Borromee, Quebec, Kanada
        • 1160.71.0699 Boehringer Ingelheim Investigational Site
      • St. George-de-Beauce, Quebec, Kanada
        • 1160.71.0713 Boehringer Ingelheim Investigational Site
      • St. Hyacinthe, Quebec, Kanada
        • 1160.71.0675 Boehringer Ingelheim Investigational Site
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada
        • 1160.71.0673 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Kanada
        • 1160.71.0678 Boehringer Ingelheim Investigational Site
  • Korejská republika
      • Busan, Korejská republika
        • 1160.71.1585 Boehringer Ingelheim Investigational Site
      • Cheonan-si, Korejská republika
        • 1160.71.1586 Boehringer Ingelheim Investigational Site
      • Daegu, Korejská republika
        • 1160.71.1584 Boehringer Ingelheim Investigational Site
      • Daegu, Korejská republika
        • 1160.71.1591 Boehringer Ingelheim Investigational Site
      • Gwangju, Korejská republika
        • 1160.71.1590 Boehringer Ingelheim Investigational Site
      • Incheon, Korejská republika
        • 1160.71.1581 Boehringer Ingelheim Investigational Site
      • Seoul, Korejská republika
        • 1160.71.1582 Boehringer Ingelheim Investigational Site
      • Seoul, Korejská republika
        • 1160.71.1583 Boehringer Ingelheim Investigational Site
      • Seoul, Korejská republika
        • 1160.71.1589 Boehringer Ingelheim Investigational Site
      • Seoul, Korejská republika
        • 1160.71.1592 Boehringer Ingelheim Investigational Site
      • Seoul, Korejská republika
        • 1160.71.1593 Boehringer Ingelheim Investigational Site
  • Malajsie
      • Kuala Lumpur, Malajsie
        • 1160.71.1291 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malajsie
        • 1160.71.1292 Boehringer Ingelheim Investigational Site
  • Maďarsko
      • Budapest, Maďarsko
        • 1160.71.1011 Boehringer Ingelheim Investigational Site
      • Budapest, Maďarsko
        • 1160.71.1012 Boehringer Ingelheim Investigational Site
      • Budapest, Maďarsko
        • 1160.71.1013 Boehringer Ingelheim Investigational Site
      • Budapest, Maďarsko
        • 1160.71.1014 Boehringer Ingelheim Investigational Site
      • Budapest, Maďarsko
        • 1160.71.1015 Boehringer Ingelheim Investigational Site
      • Budapest, Maďarsko
        • 1160.71.1016 Boehringer Ingelheim Investigational Site
      • Gyongyos, Maďarsko
        • 1160.71.1020 Boehringer Ingelheim Investigational Site
      • Komarom, Maďarsko
        • 1160.71.1017 Boehringer Ingelheim Investigational Site
      • Pecs, Maďarsko
        • 1160.71.1018 Boehringer Ingelheim Investigational Site
  • Norsko
      • Gjøvik, Norsko
        • 1160.71.1396 Boehringer Ingelheim Investigational Site
      • Moss, Norsko
        • 1160.71.1393 Boehringer Ingelheim Investigational Site
      • Nordbyhagen, Norsko
        • 1160.71.1395 Boehringer Ingelheim Investigational Site
      • Oslo, Norsko
        • 1160.71.1391 Boehringer Ingelheim Investigational Site
      • Oslo, Norsko
        • 1160.71.1397 Boehringer Ingelheim Investigational Site
      • RUD, Norsko
        • 1160.71.1394 Boehringer Ingelheim Investigational Site
  • Německo
      • Berlin, Německo
        • 1160.71.0932 Boehringer Ingelheim Investigational Site
      • Berlin, Německo
        • 1160.71.0948 Boehringer Ingelheim Investigational Site
      • Berlin, Německo
        • 1160.71.0962 Boehringer Ingelheim Investigational Site
      • Bochum, Německo
        • 1160.71.0940 Boehringer Ingelheim Investigational Site
      • Dortmund, Německo
        • 1160.71.0972 Boehringer Ingelheim Investigational Site
      • Essen, Německo
        • 1160.71.0934 Boehringer Ingelheim Investigational Site
      • Frankfurt am Main, Německo
        • 1160.71.0931 Boehringer Ingelheim Investigational Site
      • Heidelberg, Německo
        • 1160.71.0943 Boehringer Ingelheim Investigational Site
      • Köln, Německo
        • 1160.71.0963 Boehringer Ingelheim Investigational Site
      • Lahr, Německo
        • 1160.71.0946 Boehringer Ingelheim Investigational Site
      • Limburg, Německo
        • 1160.71.0944 Boehringer Ingelheim Investigational Site
      • Mainz, Německo
        • 1160.71.0951 Boehringer Ingelheim Investigational Site
      • Mannheim, Německo
        • 1160.71.0933 Boehringer Ingelheim Investigational Site
      • Mannheim, Německo
        • 1160.71.0945 Boehringer Ingelheim Investigational Site
      • Mannheim, Německo
        • 1160.71.0970 Boehringer Ingelheim Investigational Site
      • Witten, Německo
        • 1160.71.0937 Boehringer Ingelheim Investigational Site
      • Wuppertal, Německo
        • 1160.71.0966 Boehringer Ingelheim Investigational Site
  • Polsko
      • Gdynia, Polsko
        • 1160.71.1436 Boehringer Ingelheim Investigational Site
      • Gdynia, Polsko
        • 1160.71.1437 Boehringer Ingelheim Investigational Site
      • Gdynia, Polsko
        • 1160.71.1438 Boehringer Ingelheim Investigational Site
      • Pulawy, Polsko
        • 1160.71.1433 Boehringer Ingelheim Investigational Site
      • Warsaw, Polsko
        • 1160.71.1431 Boehringer Ingelheim Investigational Site
      • Warsaw, Polsko
        • 1160.71.1432 Boehringer Ingelheim Investigational Site
      • Zabrze, Polsko
        • 1160.71.1434 Boehringer Ingelheim Investigational Site
  • Portugalsko
      • Amadora, Portugalsko
        • 1160.71.1456 Boehringer Ingelheim Investigational Site
      • Carnaxide, Portugalsko
        • 1160.71.1451 Boehringer Ingelheim Investigational Site
      • Coimbra, Portugalsko
        • 1160.71.1454 Boehringer Ingelheim Investigational Site
      • Coimbra, Portugalsko
        • 1160.71.1459 Boehringer Ingelheim Investigational Site
      • Covilhã, Portugalsko
        • 1160.71.1457 Boehringer Ingelheim Investigational Site
      • Porto, Portugalsko
        • 1160.71.1455 Boehringer Ingelheim Investigational Site
  • Rakousko
      • Graz, Rakousko
        • 1160.71.0543 Boehringer Ingelheim Investigational Site
      • Linz, Rakousko
        • 1160.71.0549 Boehringer Ingelheim Investigational Site
      • Wien, Rakousko
        • 1160.71.0541 Boehringer Ingelheim Investigational Site
      • Wien, Rakousko
        • 1160.71.0542 Boehringer Ingelheim Investigational Site
      • Wien, Rakousko
        • 1160.71.0545 Boehringer Ingelheim Investigational Site
      • Wien, Rakousko
        • 1160.71.0547 Boehringer Ingelheim Investigational Site
      • Wien, Rakousko
        • 1160.71.0548 Boehringer Ingelheim Investigational Site
      • Wr. Neustadt, Rakousko
        • 1160.71.0550 Boehringer Ingelheim Investigational Site
  • Rumunsko
      • Bucharest, Rumunsko
        • 1160.71.1471 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumunsko
        • 1160.71.1472 Boehringer Ingelheim Investigational Site
  • Ruská Federace
      • Moscow, Ruská Federace
        • 1160.71.1501 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1503 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1504 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1505 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1507 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1508 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1509 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1510 Boehringer Ingelheim Investigational Site
      • Moscow, Ruská Federace
        • 1160.71.1511 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Ruská Federace
        • 1160.71.1512 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Ruská Federace
        • 1160.71.1513 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Ruská Federace
        • 1160.71.1514 Boehringer Ingelheim Investigational Site
  • Singapur
      • Singapore, Singapur
        • 1160.71.1531 Boehringer Ingelheim Investigational Site
  • Slovensko
      • Banska Bystrica, Slovensko
        • 1160.71.1548 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovensko
        • 1160.71.1541 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovensko
        • 1160.71.1542 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovensko
        • 1160.71.1543 Boehringer Ingelheim Investigational Site
      • Kosice, Slovensko
        • 1160.71.1550 Boehringer Ingelheim Investigational Site
      • Zilina, Slovensko
        • 1160.71.1547 Boehringer Ingelheim Investigational Site
  • Spojené království
      • Birmingham, Spojené království
        • 1160.71.1744 Boehringer Ingelheim Investigational Site
      • Chertsey, Spojené království
        • 1160.71.1746 Boehringer Ingelheim Investigational Site
      • County Armagh, Spojené království
        • 1160.71.1745 Boehringer Ingelheim Investigational Site
      • Kirkcaldy, Fife, Spojené království
        • 1160.71.1755 Boehringer Ingelheim Investigational Site
      • London, Spojené království
        • 1160.71.1741 Boehringer Ingelheim Investigational Site
      • Newcastle upon Tyne, Spojené království
        • 1160.71.1742 Boehringer Ingelheim Investigational Site
      • Newport, Spojené království
        • 1160.71.1751 Boehringer Ingelheim Investigational Site
      • Northampton, Spojené království
        • 1160.71.1752 Boehringer Ingelheim Investigational Site
      • Romford, Essex, Spojené království
        • 1160.71.1743 Boehringer Ingelheim Investigational Site
      • York, Spojené království
        • 1160.71.1748 Boehringer Ingelheim Investigational Site
  • Spojené státy
    • Alabama
      • Birmingham, Alabama, Spojené státy
        • 1160.71.0046 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Spojené státy
        • 1160.71.0057 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Spojené státy
        • 1160.71.0211 Boehringer Ingelheim Investigational Site
      • Mobile, Alabama, Spojené státy
        • 1160.71.0115 Boehringer Ingelheim Investigational Site
    • Arizona
      • Lake Havasu City, Arizona, Spojené státy
        • 1160.71.0104 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Spojené státy
        • 1160.71.0185 Boehringer Ingelheim Investigational Site
    • Arkansas
      • Hot Springs, Arkansas, Spojené státy
        • 1160.71.0038 Boehringer Ingelheim Investigational Site
      • Jonesboro, Arkansas, Spojené státy
        • 1160.71.0302 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Spojené státy
        • 1160.71.0191 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Spojené státy
        • 1160.71.0213 Boehringer Ingelheim Investigational Site
    • California
      • Carmichael, California, Spojené státy
        • 1160.71.0441 Boehringer Ingelheim Investigational Site
      • Fullerton, California, Spojené státy
        • 1160.71.0333 Boehringer Ingelheim Investigational Site
      • La Jolla, California, Spojené státy
        • 1160.71.0384 Boehringer Ingelheim Investigational Site
      • Lancaster, California, Spojené státy
        • 1160.71.0246 Boehringer Ingelheim Investigational Site
      • Merced, California, Spojené státy
        • 1160.71.0070 Boehringer Ingelheim Investigational Site
      • Oakland, California, Spojené státy
        • 1160.71.0349 Boehringer Ingelheim Investigational Site
      • Oceanside, California, Spojené státy
        • 1160.71.0016 Boehringer Ingelheim Investigational Site
      • Pasadena, California, Spojené státy
        • 1160.71.0459 Boehringer Ingelheim Investigational Site
      • Poway, California, Spojené státy
        • 1160.71.0270 Boehringer Ingelheim Investigational Site
      • Riverside, California, Spojené státy
        • 1160.71.0135 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Spojené státy
        • 1160.71.0300 Boehringer Ingelheim Investigational Site
      • San Diego, California, Spojené státy
        • 1160.71.0284 Boehringer Ingelheim Investigational Site
      • Walnut Creek, California, Spojené státy
        • 1160.71.0379 Boehringer Ingelheim Investigational Site
    • Colorado
      • Colorado Springs, Colorado, Spojené státy
        • 1160.71.0321 Boehringer Ingelheim Investigational Site
      • Colorado Springs, Colorado, Spojené státy
        • 1160.71.0449 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Spojené státy
        • 1160.71.0360 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Spojené státy
        • 1160.71.0413 Boehringer Ingelheim Investigational Site
      • Fort Collins, Colorado, Spojené státy
        • 1160.71.0362 Boehringer Ingelheim Investigational Site
    • Connecticut
      • Bridgeport, Connecticut, Spojené státy
        • 1160.71.0278 Boehringer Ingelheim Investigational Site
      • Guilford, Connecticut, Spojené státy
        • 1160.71.0482 Boehringer Ingelheim Investigational Site
    • Florida
      • Boynton Beach, Florida, Spojené státy
        • 1160.71.0382 Boehringer Ingelheim Investigational Site
      • Brandon, Florida, Spojené státy
        • 1160.71.0056 Boehringer Ingelheim Investigational Site
      • Clearwater, Florida, Spojené státy
        • 1160.71.0296 Boehringer Ingelheim Investigational Site
      • Coral Springs, Florida, Spojené státy
        • 1160.71.0327 Boehringer Ingelheim Investigational Site
      • Daytona Beach, Florida, Spojené státy
        • 1160.71.0376 Boehringer Ingelheim Investigational Site
      • Fort Myers, Florida, Spojené státy
        • 1160.71.0074 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Spojené státy
        • 1160.71.0089 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Spojené státy
        • 1160.71.0232 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Spojené státy
        • 1160.71.0427 Boehringer Ingelheim Investigational Site
      • Lakeland, Florida, Spojené státy
        • 1160.71.0012 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Spojené státy
        • 1160.71.0034 Boehringer Ingelheim Investigational Site
      • Orlando, Florida, Spojené státy
        • 1160.71.0227 Boehringer Ingelheim Investigational Site
      • Ormond Beach, Florida, Spojené státy
        • 1160.71.0095 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Spojené státy
        • 1160.71.0037 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Spojené státy
        • 1160.71.0137 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Spojené státy
        • 1160.71.0417 Boehringer Ingelheim Investigational Site
      • Rockledge, Florida, Spojené státy
        • 1160.71.0332 Boehringer Ingelheim Investigational Site
      • Sarasota, Florida, Spojené státy
        • 1160.71.0385 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Spojené státy
        • 1160.71.0015 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Spojené státy
        • 1160.71.0339 Boehringer Ingelheim Investigational Site
      • Vero Beach, Florida, Spojené státy
        • 1160.71.0019 Boehringer Ingelheim Investigational Site
    • Georgia
      • Atlanta, Georgia, Spojené státy
        • 1160.71.0159 Boehringer Ingelheim Investigational Site
      • Augusta, Georgia, Spojené státy
        • 1160.71.0021 Boehringer Ingelheim Investigational Site
      • Conyers, Georgia, Spojené státy
        • 1160.71.0161 Boehringer Ingelheim Investigational Site
    • Illinois
      • Cicero, Illinois, Spojené státy
        • 1160.71.0218 Boehringer Ingelheim Investigational Site
      • Maywood, Illinois, Spojené státy
        • 1160.71.0438 Boehringer Ingelheim Investigational Site
      • Melrose Park, Illinois, Spojené státy
        • 1160.71.0331 Boehringer Ingelheim Investigational Site
      • Normal, Illinois, Spojené státy
        • 1160.71.0364 Boehringer Ingelheim Investigational Site
      • North Chicago, Illinois, Spojené státy
        • 1160.71.0109 Boehringer Ingelheim Investigational Site
      • Oak Lawn, Illinois, Spojené státy
        • 1160.71.0152 Boehringer Ingelheim Investigational Site
      • Rockford, Illinois, Spojené státy
        • 1160.71.0198 Boehringer Ingelheim Investigational Site
      • Winfield, Illinois, Spojené státy
        • 1160.71.0433 Boehringer Ingelheim Investigational Site
    • Indiana
      • Fort Wayne, Indiana, Spojené státy
        • 1160.71.0377 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Spojené státy
        • 1160.71.0288 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Spojené státy
        • 1160.71.0352 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Spojené státy
        • 1160.71.0436 Boehringer Ingelheim Investigational Site
      • South Bend, Indiana, Spojené státy
        • 1160.71.0235 Boehringer Ingelheim Investigational Site
    • Iowa
      • Dubuque, Iowa, Spojené státy
        • 1160.71.0268 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Spojené státy
        • 1160.71.0001 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Spojené státy
        • 1160.71.0357 Boehringer Ingelheim Investigational Site
    • Kentucky
      • Lexington, Kentucky, Spojené státy
        • 1160.71.0422 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Spojené státy
        • 1160.71.0178 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Spojené státy
        • 1160.71.0397 Boehringer Ingelheim Investigational Site
      • Owensboro, Kentucky, Spojené státy
        • 1160.71.0310 Boehringer Ingelheim Investigational Site
    • Louisiana
      • Baton Rouge, Louisiana, Spojené státy
        • 1160.71.0144 Boehringer Ingelheim Investigational Site
      • Lafayette, Louisiana, Spojené státy
        • 1160.71.0018 Boehringer Ingelheim Investigational Site
      • New Iberia, Louisiana, Spojené státy
        • 1160.71.0132 Boehringer Ingelheim Investigational Site
    • Maine
      • Auburn, Maine, Spojené státy
        • 1160.71.0096 Boehringer Ingelheim Investigational Site
    • Maryland
      • Annapolis, Maryland, Spojené státy
        • 1160.71.0114 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Spojené státy
        • 1160.71.0023 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Spojené státy
        • 1160.71.0047 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Spojené státy
        • 1160.71.0079 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Spojené státy
        • 1160.71.0186 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Spojené státy
        • 1160.71.0194 Boehringer Ingelheim Investigational Site
      • Bel Air, Maryland, Spojené státy
        • 1160.71.0255 Boehringer Ingelheim Investigational Site
      • Columbia, Maryland, Spojené státy
        • 1160.71.0398 Boehringer Ingelheim Investigational Site
      • Rockville, Maryland, Spojené státy
        • 1160.71.0177 Boehringer Ingelheim Investigational Site
      • Salisbury, Maryland, Spojené státy
        • 1160.71.0073 Boehringer Ingelheim Investigational Site
      • Salisbury, Maryland, Spojené státy
        • 1160.71.0207 Boehringer Ingelheim Investigational Site
      • Takoma Park, Maryland, Spojené státy
        • 1160.71.0196 Boehringer Ingelheim Investigational Site
      • Towson, Maryland, Spojené státy
        • 1160.71.0187 Boehringer Ingelheim Investigational Site
      • Westminster, Maryland, Spojené státy
        • 1160.71.0052 Boehringer Ingelheim Investigational Site
    • Massachusetts
      • Haverhill, Massachusetts, Spojené státy
        • 1160.71.0443 Boehringer Ingelheim Investigational Site
      • Haverhill, Massachusetts, Spojené státy
        • 1160.71.0452 Boehringer Ingelheim Investigational Site
      • Natick, Massachusetts, Spojené státy
        • 1160.71.0029 Boehringer Ingelheim Investigational Site
      • North Dartmouth, Massachusetts, Spojené státy
        • 1160.71.0003 Boehringer Ingelheim Investigational Site
      • Worcester, Massachusetts, Spojené státy
        • 1160.71.0308 Boehringer Ingelheim Investigational Site
    • Michigan
      • Grand Blanc, Michigan, Spojené státy
        • 1160.71.0154 Boehringer Ingelheim Investigational Site
      • Lapeer, Michigan, Spojené státy
        • 1160.71.0205 Boehringer Ingelheim Investigational Site
      • Muskegon, Michigan, Spojené státy
        • 1160.71.0279 Boehringer Ingelheim Investigational Site
      • Petoskey, Michigan, Spojené státy
        • 1160.71.0445 Boehringer Ingelheim Investigational Site
      • Rochester Hills, Michigan, Spojené státy
        • 1160.71.0274 Boehringer Ingelheim Investigational Site
      • Saginaw, Michigan, Spojené státy
        • 1160.71.0165 Boehringer Ingelheim Investigational Site
      • Troy, Michigan, Spojené státy
        • 1160.71.0020 Boehringer Ingelheim Investigational Site
      • Ypsilanti, Michigan, Spojené státy
        • 1160.71.0188 Boehringer Ingelheim Investigational Site
    • Minnesota
      • Minneapolis, Minnesota, Spojené státy
        • 1160.71.0202 Boehringer Ingelheim Investigational Site
      • St. Paul, Minnesota, Spojené státy
        • 1160.71.0101 Boehringer Ingelheim Investigational Site
    • Mississippi
      • Gulfport, Mississippi, Spojené státy
        • 1160.71.0086 Boehringer Ingelheim Investigational Site
      • Tupelo, Mississippi, Spojené státy
        • 1160.71.0119 Boehringer Ingelheim Investigational Site
    • Missouri
      • Columbia, Missouri, Spojené státy
        • 1160.71.0055 Boehringer Ingelheim Investigational Site
      • Kansas City, Missouri, Spojené státy
        • 1160.71.0257 Boehringer Ingelheim Investigational Site
      • St. Charles, Missouri, Spojené státy
        • 1160.71.0336 Boehringer Ingelheim Investigational Site
      • St. Louis, Missouri, Spojené státy
        • 1160.71.0249 Boehringer Ingelheim Investigational Site
    • Montana
      • Kalispell, Montana, Spojené státy
        • 1160.71.0027 Boehringer Ingelheim Investigational Site
    • Nebraska
      • Omaha, Nebraska, Spojené státy
        • 1160.71.0110 Boehringer Ingelheim Investigational Site
    • Nevada
      • Henderson, Nevada, Spojené státy
        • 1160.71.0346 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Spojené státy
        • 1160.71.0430 Boehringer Ingelheim Investigational Site
    • New Jersey
      • Browns Mills, New Jersey, Spojené státy
        • 1160.71.0142 Boehringer Ingelheim Investigational Site
      • Cherry Hill, New Jersey, Spojené státy
        • 1160.71.0221 Boehringer Ingelheim Investigational Site
      • Flemington, New Jersey, Spojené státy
        • 1160.71.0248 Boehringer Ingelheim Investigational Site
      • Oakland, New Jersey, Spojené státy
        • 1160.71.0478 Boehringer Ingelheim Investigational Site
      • Ocean, New Jersey, Spojené státy
        • 1160.71.0392 Boehringer Ingelheim Investigational Site
      • Westwood, New Jersey, Spojené státy
        • 1160.71.0254 Boehringer Ingelheim Investigational Site
      • Woodland Park, New Jersey, Spojené státy
        • 1160.71.0472 Boehringer Ingelheim Investigational Site
    • New York
      • Albany, New York, Spojené státy
        • 1160.71.0476 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Spojené státy
        • 1160.71.0113 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Spojené státy
        • 1160.71.0281 Boehringer Ingelheim Investigational Site
      • Cortlandt Manor, New York, Spojené státy
        • 1160.71.0044 Boehringer Ingelheim Investigational Site
      • Mineola, New York, Spojené státy
        • 1160.71.0229 Boehringer Ingelheim Investigational Site
      • Mineola, New York, Spojené státy
        • 1160.71.0451 Boehringer Ingelheim Investigational Site
      • New Rochelle, New York, Spojené státy
        • 1160.71.0183 Boehringer Ingelheim Investigational Site
      • Northport, New York, Spojené státy
        • 1160.71.0210 Boehringer Ingelheim Investigational Site
      • Poughkeepsie, New York, Spojené státy
        • 1160.71.0075 Boehringer Ingelheim Investigational Site
      • Troy, New York, Spojené státy
        • 1160.71.0414 Boehringer Ingelheim Investigational Site
      • Watertown, New York, Spojené státy
        • 1160.71.0356 Boehringer Ingelheim Investigational Site
      • Yonkers, New York, Spojené státy
        • 1160.71.0064 Boehringer Ingelheim Investigational Site
    • North Carolina
      • Asheville, North Carolina, Spojené státy
        • 1160.71.0353 Boehringer Ingelheim Investigational Site
      • Charlotte, North Carolina, Spojené státy
        • 1160.71.0080 Boehringer Ingelheim Investigational Site
      • Gastonia, North Carolina, Spojené státy
        • 1160.71.0350 Boehringer Ingelheim Investigational Site
      • High Point, North Carolina, Spojené státy
        • 1160.71.0173 Boehringer Ingelheim Investigational Site
      • Pinehurst, North Carolina, Spojené státy
        • 1160.71.0006 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Spojené státy
        • 1160.71.0002 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Spojené státy
        • 1160.71.0069 Boehringer Ingelheim Investigational Site
    • North Dakota
      • Grand Forks, North Dakota, Spojené státy
        • 1160.71.0102 Boehringer Ingelheim Investigational Site
      • Jamestown, North Dakota, Spojené státy
        • 1160.71.0222 Boehringer Ingelheim Investigational Site
    • Ohio
      • Akron, Ohio, Spojené státy
        • 1160.71.0203 Boehringer Ingelheim Investigational Site
      • Canal Fulton, Ohio, Spojené státy
        • 1160.71.0434 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Spojené státy
        • 1160.71.0402 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Spojené státy
        • 1160.71.0426 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Spojené státy
        • 1160.71.0479 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Spojené státy
        • 1160.71.0263 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Spojené státy
        • 1160.71.0480 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Spojené státy
        • 1160.71.0267 Boehringer Ingelheim Investigational Site
      • Dayton, Ohio, Spojené státy
        • 1160.71.0035 Boehringer Ingelheim Investigational Site
      • Fairview Park, Ohio, Spojené státy
        • 1160.71.0150 Boehringer Ingelheim Investigational Site
      • Kettering, Ohio, Spojené státy
        • 1160.71.0201 Boehringer Ingelheim Investigational Site
      • Lorain, Ohio, Spojené státy
        • 1160.71.0223 Boehringer Ingelheim Investigational Site
      • Lyndhurst, Ohio, Spojené státy
        • 1160.71.0214 Boehringer Ingelheim Investigational Site
      • Sandusky, Ohio, Spojené státy
        • 1160.71.0275 Boehringer Ingelheim Investigational Site
      • Westlake, Ohio, Spojené státy
        • 1160.71.0103 Boehringer Ingelheim Investigational Site
    • Oklahoma
      • Tulsa, Oklahoma, Spojené státy
        • 1160.71.0435 Boehringer Ingelheim Investigational Site
    • Oregon
      • Corvallis, Oregon, Spojené státy
        • 1160.71.0139 Boehringer Ingelheim Investigational Site
      • Eugene, Oregon, Spojené státy
        • 1160.71.0325 Boehringer Ingelheim Investigational Site
      • Springfield, Oregon, Spojené státy
        • 1160.71.0133 Boehringer Ingelheim Investigational Site
    • Pennsylvania
      • Allentown, Pennsylvania, Spojené státy
        • 1160.71.0301 Boehringer Ingelheim Investigational Site
      • Camp Hill, Pennsylvania, Spojené státy
        • 1160.71.0295 Boehringer Ingelheim Investigational Site
      • Hershey, Pennsylvania, Spojené státy
        • 1160.71.0294 Boehringer Ingelheim Investigational Site
      • Jenkintown, Pennsylvania, Spojené státy
        • 1160.71.0369 Boehringer Ingelheim Investigational Site
      • Lancaster, Pennsylvania, Spojené státy
        • 1160.71.0431 Boehringer Ingelheim Investigational Site
      • Langhorne, Pennsylvania, Spojené státy
        • 1160.71.0168 Boehringer Ingelheim Investigational Site
      • Meadowbrook, Pennsylvania, Spojené státy
        • 1160.71.0293 Boehringer Ingelheim Investigational Site
      • Norristown, Pennsylvania, Spojené státy
        • 1160.71.0394 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Spojené státy
        • 1160.71.0466 Boehringer Ingelheim Investigational Site
      • Sellersville, Pennsylvania, Spojené státy
        • 1160.71.0208 Boehringer Ingelheim Investigational Site
      • Uniontown, Pennsylvania, Spojené státy
        • 1160.71.0465 Boehringer Ingelheim Investigational Site
      • Wynnewood, Pennsylvania, Spojené státy
        • 1160.71.0032 Boehringer Ingelheim Investigational Site
      • Wyomissing, Pennsylvania, Spojené státy
        • 1160.71.0067 Boehringer Ingelheim Investigational Site
    • South Carolina
      • Beaufort, South Carolina, Spojené státy
        • 1160.71.0007 Boehringer Ingelheim Investigational Site
      • Charleston, South Carolina, Spojené státy
        • 1160.71.0383 Boehringer Ingelheim Investigational Site
      • Greenville, South Carolina, Spojené státy
        • 1160.71.0313 Boehringer Ingelheim Investigational Site
      • Spartanburg, South Carolina, Spojené státy
        • 1160.71.0166 Boehringer Ingelheim Investigational Site
      • Summerville, South Carolina, Spojené státy
        • 1160.71.0008 Boehringer Ingelheim Investigational Site
    • Tennessee
      • Chattanooga, Tennessee, Spojené státy
        • 1160.71.0084 Boehringer Ingelheim Investigational Site
      • Clinton, Tennessee, Spojené státy
        • 1160.71.0474 Boehringer Ingelheim Investigational Site
      • Germantown, Tennessee, Spojené státy
        • 1160.71.0062 Boehringer Ingelheim Investigational Site
      • Johnson City, Tennessee, Spojené státy
        • 1160.71.0370 Boehringer Ingelheim Investigational Site
      • Nashville, Tennessee, Spojené státy
        • 1160.71.0395 Boehringer Ingelheim Investigational Site
    • Texas
      • Austin, Texas, Spojené státy
        • 1160.71.0129 Boehringer Ingelheim Investigational Site
      • Austin, Texas, Spojené státy
        • 1160.71.0410 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Spojené státy
        • 1160.71.0156 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Spojené státy
        • 1160.71.0315 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Spojené státy
        • 1160.71.0447 Boehringer Ingelheim Investigational Site
      • Killeen, Texas, Spojené státy
        • 1160.71.0483 Boehringer Ingelheim Investigational Site
      • Lubbock, Texas, Spojené státy
        • 1160.71.0335 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Spojené státy
        • 1160.71.0269 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Spojené státy
        • 1160.71.0307 Boehringer Ingelheim Investigational Site
      • San Marcos, Texas, Spojené státy
        • 1160.71.0285 Boehringer Ingelheim Investigational Site
      • Tyler, Texas, Spojené státy
        • 1160.71.0367 Boehringer Ingelheim Investigational Site
    • Virginia
      • Charlottesville, Virginia, Spojené státy
        • 1160.71.0453 Boehringer Ingelheim Investigational Site
      • Chesapeake, Virginia, Spojené státy
        • 1160.71.0053 Boehringer Ingelheim Investigational Site
      • Fredericksburg, Virginia, Spojené státy
        • 1160.71.0428 Boehringer Ingelheim Investigational Site
      • Harrisonburg, Virginia, Spojené státy
        • 1160.71.0311 Boehringer Ingelheim Investigational Site
      • Newport News, Virginia, Spojené státy
        • 1160.71.0292 Boehringer Ingelheim Investigational Site
      • Salem, Virginia, Spojené státy
        • 1160.71.0220 Boehringer Ingelheim Investigational Site
      • Suffolk, Virginia, Spojené státy
        • 1160.71.0224 Boehringer Ingelheim Investigational Site
      • Winchester, Virginia, Spojené státy
        • 1160.71.0317 Boehringer Ingelheim Investigational Site
    • Washington
      • Bellingham, Washington, Spojené státy
        • 1160.71.0050 Boehringer Ingelheim Investigational Site
      • Burien, Washington, Spojené státy
        • 1160.71.0040 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Spojené státy
        • 1160.71.0250 Boehringer Ingelheim Investigational Site
      • Tacoma, Washington, Spojené státy
        • 1160.71.0256 Boehringer Ingelheim Investigational Site
      • Wenatchee, Washington, Spojené státy
        • 1160.71.0024 Boehringer Ingelheim Investigational Site
    • West Virginia
      • Clarksburg, West Virginia, Spojené státy
        • 1160.71.0169 Boehringer Ingelheim Investigational Site
      • Huntington, West Virginia, Spojené státy
        • 1160.71.0365 Boehringer Ingelheim Investigational Site
    • Wisconsin
      • Madison, Wisconsin, Spojené státy
        • 1160.71.0099 Boehringer Ingelheim Investigational Site
      • Milwaukee, Wisconsin, Spojené státy
        • 1160.71.0072 Boehringer Ingelheim Investigational Site
      • Milwaukee, Wisconsin, Spojené státy
        • 1160.71.0461 Boehringer Ingelheim Investigational Site
  • Tchaj-wan
      • Changhua, Tchaj-wan
        • 1160.71.1680 Boehringer Ingelheim Investigational Site
      • Hualien, Tchaj-wan
        • 1160.71.1683 Boehringer Ingelheim Investigational Site
      • Kaohsiung, Tchaj-wan
        • 1160.71.1682 Boehringer Ingelheim Investigational Site
      • Taichung, Tchaj-wan
        • 1160.71.1679 Boehringer Ingelheim Investigational Site
      • Tainan, Tchaj-wan
        • 1160.71.1681 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1671 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1672 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1673 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1674 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1675 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1676 Boehringer Ingelheim Investigational Site
      • Taipei, Tchaj-wan
        • 1160.71.1677 Boehringer Ingelheim Investigational Site
      • Taoyuan, Tchaj-wan
        • 1160.71.1678 Boehringer Ingelheim Investigational Site
  • Thajsko
      • Bangkok, Thajsko
        • 1160.71.1701 Boehringer Ingelheim Investigational Site
      • Chiang Mai, Thajsko
        • 1160.71.1703 Boehringer Ingelheim Investigational Site
      • Khon Kaen, Thajsko
        • 1160.71.1704 Boehringer Ingelheim Investigational Site
  • Česká republika
      • Modrice, Česká republika
        • 1160.71.0816 Boehringer Ingelheim Investigational Site
      • Ostrava 1, Česká republika
        • 1160.71.0820 Boehringer Ingelheim Investigational Site
      • Pardubice, Česká republika
        • 1160.71.0818 Boehringer Ingelheim Investigational Site
      • Plzen-Bory, Česká republika
        • 1160.71.0814 Boehringer Ingelheim Investigational Site
      • Praha 5, Česká republika
        • 1160.71.0811 Boehringer Ingelheim Investigational Site
      • Praha 6, Česká republika
        • 1160.71.0812 Boehringer Ingelheim Investigational Site
      • Praha 9, Česká republika
        • 1160.71.0813 Boehringer Ingelheim Investigational Site
      • Pribram, Česká republika
        • 1160.71.0817 Boehringer Ingelheim Investigational Site
      • Usti nad Orlici, Česká republika
        • 1160.71.0819 Boehringer Ingelheim Investigational Site
  • Čína
      • Beijing, Čína
        • 1160.71.0771 Boehringer Ingelheim Investigational Site
      • Beijing, Čína
        • 1160.71.0772 Boehringer Ingelheim Investigational Site
      • Beijing, Čína
        • 1160.71.0773 Boehringer Ingelheim Investigational Site
      • Beijing, Čína
        • 1160.71.0774 Boehringer Ingelheim Investigational Site
      • Haerbin, Čína
        • 1160.71.0776 Boehringer Ingelheim Investigational Site
      • Hangzhou, Čína
        • 1160.71.0784 Boehringer Ingelheim Investigational Site
      • QingDao, Čína
        • 1160.71.0778 Boehringer Ingelheim Investigational Site
      • Shanghai, Čína
        • 1160.71.0781 Boehringer Ingelheim Investigational Site
      • Shanghai, Čína
        • 1160.71.0782 Boehringer Ingelheim Investigational Site
      • Shenyang, Čína
        • 1160.71.0777 Boehringer Ingelheim Investigational Site
      • Shijiazhuang, Čína
        • 1160.71.0780 Boehringer Ingelheim Investigational Site
  • Řecko
      • Athens, Řecko
        • 1160.71.0901 Boehringer Ingelheim Investigational Site
      • Kalamaria-Thessaloniki, Řecko
        • 1160.71.0914 Boehringer Ingelheim Investigational Site
      • Larissa, Řecko
        • 1160.71.0904 Boehringer Ingelheim Investigational Site
      • Thiva, Řecko
        • 1160.71.0910 Boehringer Ingelheim Investigational Site
      • Trikala, Řecko
        • 1160.71.0903 Boehringer Ingelheim Investigational Site
      • Voula - Athens, Řecko
        • 1160.71.0905 Boehringer Ingelheim Investigational Site
  • Švédsko
      • Göteborg, Švédsko
        • 1160.71.1633 Boehringer Ingelheim Investigational Site
      • Malmö, Švédsko
        • 1160.71.1627 Boehringer Ingelheim Investigational Site
      • Norrköping, Švédsko
        • 1160.71.1625 Boehringer Ingelheim Investigational Site
      • Nässjö, Švédsko
        • 1160.71.1628 Boehringer Ingelheim Investigational Site
      • Stockholm, Švédsko
        • 1160.71.1626 Boehringer Ingelheim Investigational Site
      • Stockholm, Švédsko
        • 1160.71.1634 Boehringer Ingelheim Investigational Site
      • Umeå, Švédsko
        • 1160.71.1624 Boehringer Ingelheim Investigational Site
      • Uppsala, Švédsko
        • 1160.71.1621 Boehringer Ingelheim Investigational Site
      • Uppsala, Švédsko
        • 1160.71.1635 Boehringer Ingelheim Investigational Site
      • Västerås, Švédsko
        • 1160.71.1622 Boehringer Ingelheim Investigational Site
      • Örebro, Švédsko
        • 1160.71.1623 Boehringer Ingelheim Investigational Site
  • Švýcarsko
      • Basel, Švýcarsko
        • 1160.71.1652 Boehringer Ingelheim Investigational Site
      • Bellinzona, Švýcarsko
        • 1160.71.1655 Boehringer Ingelheim Investigational Site
      • Bern, Švýcarsko
        • 1160.71.1651 Boehringer Ingelheim Investigational Site
      • Lugano, Švýcarsko
        • 1160.71.1654 Boehringer Ingelheim Investigational Site

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let a starší (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion criteria:

Participation in RE-LY, requires long term anticoagulation, provides written informed consent

Exclusion criteria:

Permanent discontinuation of dabigatran during RE-LY

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Dvojnásobek

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: dabigatran dose 1
dabigatran high dose twice daily
Lék: dabigatran dose 1
dabigatran high dose twice daily
Experimentální: dabigatran dose 2
dabigatran low dose twice daily
Lék: dabigatran dose 2
dabigatran low dose twice daily

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Major Bleeding, Annualized Rate of Subjects With Major Bleeds
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Major bleeding must have satisfied one or more of the following criteria:

  • Bleeding associated with a reduction in hemoglobin of at least 20 g/L
  • Required transfusion of at least 2 units of blood or packed cells
  • Symptomatic bleeding in a critical area or organ: intraocular, intraspinal, intramuscular with compartment syndrome, retroperitoneal, intra-articular, pericardial, gastrointestinal

Major bleed were classified as life-threatening if they met one or more of the following criteria:

  • Reduction in hemoglobin of at least 50 g/L
  • Transfusion of at least 4 units of blood or packed cells
  • Symptomatic intracranial bleeding, either subdural or intracerebral
  • Associated with hypotension requiring use of intravenous inotropic agents
  • Required surgical intervention to stop bleeding
  • Resulted in death
up to 43 months

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Stroke, Annualized Rate of Subjects With Stroke
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Stroke was an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke was categorized as ischemic or hemorrhagic or cause unknown based on computerized tomography (CT), magnetic resonance (MR) scanning or autopsy. Fatal stroke was defined as death from any cause within 30 days of stroke. Severity of stroke was assessed by modified Rankin score at discharge from hospital
up to 43 months
Non CNS Systemic Embolism (SEE), Annualized Rate of Subjects With Non-CNS SEE
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Systemic embolism was an acute vascular occlusion of the extremities or any organ (kidneys, mesenteric arteries, spleen, retina or grafts), and was to be documented by angiography, surgery, scintigraphy, or autopsy.
up to 43 months
Pulmonary Embolism (PE), Annualized Rate of Subjects With PE
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Pulmonary Embolism was generally documented by one of the following:

  1. an intraluminal filling defect in segmental or more proximal branches on spiral CT scan
  2. an intraluminal filling defect or an extension of an existing defect or a sudden cutoff of vessels more than 2.5 mm in diameter on the pulmonary angiogram
  3. a perfusion defect of at least 75% of a segment with a local normal ventilation result (high-probability) on ventilation/perfusion lung scan (VPLS)
  4. inconclusive spiral CT, pulmonary angiography or lung scintigraphy with demonstration of DVT in the lower extremities by compression ultrasound or venography.
up to 43 months
Acute Myocardial Infarction (MI), Annualized Rate of Subjects With MI
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

a. In subjects not undergoing PCI or CABG a subject should have fulfilled at least 2 of the following: i. Typical prolonged severe chest pain or related symptoms or signs suggestive of MI. ii. Elevation of troponin or CK-MB to more than upper level of normal (ULN) or, if CK-MB was elevated at baseline, re-elevation to more than 50% increase above the previous level. iii. Development of significant Q-waves in at least 2 adjacent ECG leads. b. After percutaneous coronary intervention (within 24h). c. After coronary artery bypass grafting (within 72h). d. Silent myocardial infarction. e. Myocardial infarction could also have been demonstrated at autopsy.
up to 43 months
Deep Vein Thrombosis, Annualized Rate of Subjects With DVT
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Deep Vein Thrombosis (DVT) was generally documented by one of the following:

  1. abnormal compression ultrasound (CUS),
  2. an intraluminal filling defect on venography.
up to 43 months
Death, Annualized Rate of Subject Death
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Deaths were classified as being vascular (sudden/arrhythmic, pump failure death, or other vascular, including bleeding) or non-vascular, due to other specified causes (e.g., malignancy), or of unknown etiology.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE)
Časové okno: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) and All Cause Death
Časové okno: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction, Vascular Death
Časové okno: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction (MI), All Cause Death and Major Bleed
Časové okno: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Minor Bleeds
Časové okno: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Minor bleeds were clinical bleeds that did not fulfill the criteria for major bleeds. Minor bleeds were classified as associated with study medication discontinuation (temporary or permanent) or not.
up to 43 months
Annualized Rate of Subjects With Any Bleeds (Major Plus Minor)
Časové okno: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Intra-Cranial Hemorrhage (ICH)
Časové okno: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Boehringer Ingelheim

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Užitečné odkazy

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia

1. listopadu 2008

Primární dokončení (Aktuální)

1. prosince 2012

Dokončení studie (Aktuální)

1. prosince 2012

Termíny zápisu do studia

První předloženo

12. prosince 2008

První předloženo, které splnilo kritéria kontroly kvality

12. prosince 2008

První zveřejněno (Odhad)

15. prosince 2008

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Odhad)

9. června 2014

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

3. června 2014

Naposledy ověřeno

1. března 2014

Více informací

Termíny související s touto studií

Další relevantní podmínky MeSH

Další identifikační čísla studie

  • 1160.71
  • 2008-005248-17 (Číslo EudraCT: EudraCT)

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit